FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

The final, formatted version of the article will be published soon. Complex gill disease (CGD) of farmed Atlantic salmon (Salmo salar) is currently one of the most significant health problems in the ...

Heart disease continues to stand as the No. 1 cause of death in the United States. Coronary heart disease, the most common type of heart disease in the U.S., was responsible for the deaths of nearly ...

Millions of adults in their 20s or older have coronary artery disease. But experts say the common condition doesn’t have to be an inevitable part of aging. There are steps you can take to reduce your ...

The Tennessee Wildlife Resource Agency said they're tracking instance of hemorrhagic disease. Unlike chronic wasting diease, hemorrhagic disease is not always fatal. Hemorrhagic disease is spread to ...

The FDA has issued a manufacturing-related complete response letter for Cyprium Therapeutics’ copper histidinate drug candidate CUTX-101, raising a roadblock on the path to commercializing the first ...

Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But last ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal neurodegenerative condition. Scientists from University College London (UCL) found patients ...

University of Victoria provides funding as a member of The Conversation CA-FR. University of Victoria provides funding as a member of The Conversation CA. Research has revealed a steep increase in ...